HOUSE BILL 370
RS30657 / H0370
This legislation would provide for a tightly regulated system for medical cannabis. Patients diagnosed with a substantial health condition such as cancer, ALS, AIDS, wasting syndrome, Crohn’s disease, epilepsy, debilitating seizures, and terminal illness, would be eligible for a medical cannabis card. Medical cannabis cards would be valid for up to a maximum of one year, upon which a renewal must be sought.
“Medical cannabis” is defined as an “ingestible cannabis processed to a tablet, chewable, droplet, or pill containing up to ten (10) milligrams of tetrahydrocannabinol,” and does not include any type of raw, smoked or vaped form. A cardholder must obtain medical cannabis from an Idaho licensed pharmacist.
Producers of medical cannabis would have to obtain a production license in Idaho to grow and handle medical cannabis and be strictly regulated including the submission of an operating plan, inspections, testing of product and criminal background checks.
This legislation does not have an impact on the State’s General Fund because fees will cover the administration of the program. There will be no impact on any dedicated fund or federal fund by removing or rescheduling products to the Controlled Substances Act.
Date | Description |
---|---|
03/24 | Introduced, read first time, referred to JRA for Printing |
Reported Printed; Filed in the Office of the Chief Clerk |